Caisse DE Depot ET Placement DU Quebec purchased a new stake in shares of Iqvia Holdings Inc (NYSE:IQV) in the fourth quarter, according to its most recent filing with the SEC. The firm purchased 17,962 shares of the medical research company’s stock, valued at approximately $1,758,000.
Several other hedge funds also recently bought and sold shares of IQV. BlackRock Inc. purchased a new stake in Iqvia in the 4th quarter worth approximately $942,532,000. Longview Partners Guernsey LTD purchased a new stake in shares of Iqvia during the 4th quarter valued at $927,548,000. Jackson Square Partners LLC purchased a new stake in shares of Iqvia during the 4th quarter valued at $464,053,000. Alliancebernstein L.P. purchased a new stake in shares of Iqvia during the 4th quarter valued at $253,128,000. Finally, Geode Capital Management LLC purchased a new stake in shares of Iqvia during the 4th quarter valued at $151,538,000. Institutional investors own 92.34% of the company’s stock.
IQV traded down $2.15 on Friday, hitting $94.85. 964,842 shares of the company’s stock were exchanged, compared to its average volume of 905,586. The firm has a market cap of $20,202.20, a price-to-earnings ratio of 21.75, a price-to-earnings-growth ratio of 1.40 and a beta of 0.63. Iqvia Holdings Inc has a twelve month low of $78.09 and a twelve month high of $110.67. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 1.21.
Iqvia (NYSE:IQV) last released its quarterly earnings data on Wednesday, February 14th. The medical research company reported $1.32 earnings per share for the quarter, missing the consensus estimate of $1.34 by ($0.02). The business had revenue of $2.16 billion for the quarter, compared to analyst estimates of $2.14 billion. Iqvia had a return on equity of 13.03% and a net margin of 13.44%. Iqvia’s revenue was up 10.7% compared to the same quarter last year. During the same quarter last year, the company earned $1.09 EPS. research analysts anticipate that Iqvia Holdings Inc will post 5.02 earnings per share for the current year.
IQV has been the subject of several research reports. Evercore ISI initiated coverage on shares of Iqvia in a research note on Thursday, January 18th. They set an “outperform” rating and a $112.00 price objective for the company. Zacks Investment Research cut shares of Iqvia from a “hold” rating to a “sell” rating in a research note on Tuesday, February 20th. Mitsubishi UFJ Financial Group started coverage on shares of Iqvia in a research report on Friday, December 15th. They set a “neutral” rating and a $112.00 price target for the company. SunTrust Banks reaffirmed a “hold” rating and set a $110.00 price target on shares of Iqvia in a research report on Monday, January 22nd. Finally, Piper Jaffray reaffirmed a “hold” rating and set a $103.00 price target on shares of Iqvia in a research report on Thursday, February 15th. Eight equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $110.02.
In other news, insider James H. Erlinger III sold 10,000 shares of the stock in a transaction that occurred on Wednesday, January 17th. The shares were sold at an average price of $99.97, for a total value of $999,700.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Robert Parks sold 896 shares of the stock in a transaction that occurred on Thursday, March 15th. The shares were sold at an average price of $105.73, for a total transaction of $94,734.08. The disclosure for this sale can be found here. In the last 90 days, insiders sold 21,712 shares of company stock valued at $2,176,034. 6.00% of the stock is owned by insiders.
TRADEMARK VIOLATION NOTICE: “Caisse DE Depot ET Placement DU Quebec Buys Shares of 17,962 Iqvia Holdings Inc (IQV)” was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another website, it was stolen and republished in violation of US & international trademark & copyright legislation. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2018/04/07/17962-shares-in-iqvia-holdings-inc-iqv-purchased-by-caisse-de-depot-et-placement-du-quebec.html.
IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.